Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

gsk.com

Press releases

Get the latest updates from Press releases directly as they happen.

Follow now 476 followers

Latest posts

Last updated 1 day ago

Arexvy approval expanded to adults aged 50-59 at increased risk of severe RSV disease in Japan

about 19 hours ago

First RSV vaccine approved in Japan to help protect 50-59 year olds...

Company statement: GSK continues to show strong leadership in its Access to Medicines Index ranking

4 days ago

GSK is pleased to rank 2nd in the Access to Medicine Index...

Statement: GSK continues to show strong leadership in its Access to Medicines Index ranking

4 days ago

GSK is pleased to rank 2nd in the Access to Medicine Index...

Linerixibat shows positive Phase III results in cholestatic pruritus (relentless itch) in primary biliary cholangitis (PBC)

4 days ago

Primary endpoint met with a statistically significant improvement in itch over 24...

Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma

9 days ago

Full data to be presented at 2024 American Society of Hematology Annual...

GSK highlights key data from hepatology portfolio at the AASLD’s The Liver Meeting® 2024, emphasising patient impact in areas of high unmet need

10 days ago

New data shows potential for sequential therapy of bepirovirsen after daplusiran/tomligisiran to...

New GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers

11 days ago

GSK’s Your Cancer Is Our Challenge will raise awareness of barriers and...

GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline

25 days ago

Agreement reinforces GSK’s portfolio in the treatment of lupus and underlying drivers...

New data for Arexvy, GSK’s respiratory syncytial virus vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease

about 1 month ago

Single dose of vaccine elicited robust immune response with acceptable safety profile...

GSK and Cambridge University announce new five-year collaboration in kidney and respiratory disease

about 1 month ago

GSK is investing more than £50 million in the CG-TIC to further...